Evidence map›Paper›PMID 41720814›Full record

ArticleNature communications2026

Dual-role iron species in photoelectrocatalytic radical trifluoromethylation with trifluoroacetates.

Sara Fernández-García, Sara Cuadros, Irene Bosque, Jose C Gonzalez-Gomez, Francisco Juliá-Hernández

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sara Fernández-García *Facultad de Química, Centro Multidisciplinar Pleiades-Vitalis, Universidad de Murcia, Campus de Espinardo, Murcia, Spain.
Sara Cuadros *Instituto de Síntesis Orgánica (ISO) and Departamento de Química Orgánica, Universidad de Alicante, Apdo. 99, Alicante, Spain.ORCID http://orcid.org/0000-0001-6179-7306
Irene BosqueInstituto de Síntesis Orgánica (ISO) and Departamento de Química Orgánica, Universidad de Alicante, Apdo. 99, Alicante, Spain. irene.bosque@ua.es.ORCID http://orcid.org/0000-0003-0321-2167
Jose C Gonzalez-GomezInstituto de Síntesis Orgánica (ISO) and Departamento de Química Orgánica, Universidad de Alicante, Apdo. 99, Alicante, Spain. josecarlos.gonzalez@ua.es.ORCID http://orcid.org/0000-0001-5334-7938
Francisco Juliá-HernándezFacultad de Química, Centro Multidisciplinar Pleiades-Vitalis, Universidad de Murcia, Campus de Espinardo, Murcia, Spain. francisco.julia@um.es.ORCID http://orcid.org/0000-0001-5311-0957

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trifluoromethylation remains a fundamental transformation in drug discovery, underpinning many top-selling pharmaceuticals. Emerging developments in iron ligand-to-metal charge transfer (LMCT) catalysis have redefined fluoroalkylation chemistry by unlocking the repurposing of readily available trifluoroacetates as radical trifluoromethyl sources. Recent (hetero)arene trifluoromethylation methods generally require stoichiometric inorganic oxidants to turnover photoactive iron catalysts, thereby limiting their broader applicability. Herein, we present an integrated photoelectrocatalytic strategy employing in situ-generated multifunctional iron species to achieve C(sp²)-H trifluoromethylation without stoichiometric oxidants and generating only traceless byproducts. Mechanistic studies identify catalytically active iron species exhibiting a dual synergistic function: promoting the photodecarboxylation of trifluoroacetates and mediating catalytic redox turnover. This protocol offers mild, tunable, and scalable conditions powered by visible light and electric current. It features a broad substrate scope, enabling the functionalization of diverse (hetero)cyclic scaffolds, including challenging electron-rich and easily oxidizable substrates, thus demonstrating its potential for sustainable late-stage modification in pharmaceutical synthesis.

Identifiers

PMID41720814
PMCPMC13035886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.